Record Number of Abstracts Submitted to CTRC-AACR San Antonio Breast Cancer Symposium
SAN ANTONIO — This year’s CTRC-AACR San Antonio Breast Cancer Symposium received 1,641 abstract submissions before their deadline closed on June 21, 2011, an increase over the previous 2009 record of 1,464.
Selected abstracts will be presented as part of the robust program hosted by the Cancer Therapy & Research Center at UT Health Science Center in San Antonio, the American Association for Cancer Research and Baylor College of Medicine.
The symposium will be held Dec. 6-10, 2011, in San Antonio, Texas. Media registration is open and interested journalists can submit press credentials to Natalie Poole at Natalie.Poole@aacr.org.
For information on media policies, please visit: http://www.sabcs.org/Media/index.asp.
Abstracts span all categories of breast cancer care and management, including a new category called Ongoing Clinical Trials, which has received 68 submissions.
Now in its 34th year, the CTRC-AACR San Antonio Breast Cancer Symposium remains the premier venue for exciting studies in the field of breast cancer research and treatment. The program continues to present essential up-to-the-minute information and fosters discussion for basic, translational and clinical cancer research professionals.
# # #
The mission of the CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium. This collaboration utilizes the clinical strengths of the CTRC and Baylor, and the AACR’s scientific prestige in basic, translational and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic. The 34th annual symposium is expected to draw nearly 8,000 participants from more than 90 countries.